AGUIAR ERIC 4

What Happened

• Eric Aguiar, a director of Biomea Fusion, received a grant/award of 196,299 shares (reported as a derivative award) on June 10, 2026. The award was reported at $0.00, meaning no cash was paid by the insider at grant and the filing reflects a derivative instrument rather than a market purchase.

Key Details

• Transaction date: 2026-06-10; Form 4 filed: 2026-06-12 (timely filing).
• Reported transaction: Grant/award (derivative) of 196,299 shares at $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The shares underlying the stock option will vest in full upon the earlier of (i) the one‑year anniversary of the grant or (ii) immediately prior to the issuer’s next annual meeting, subject to continued service by the reporting person.
• No indication of an immediate exercise or sale; this is a time‑vested award.

Context

• This is a grant of a derivative award (likely stock options) that vests within a year, so it represents potential future ownership rather than an immediate open‑market purchase. Such awards are common for directors as part of compensation and do not by themselves indicate buying/selling sentiment.